about
IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokinesQuantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesionSOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytesAllergic contact dermatitis in psoriasis patients: typical, delayed, and non-interacting.Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cellsT-cell subpopulations in the development of atopic and contact allergy.Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide.Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo.Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces.Purinergic signaling in scarring.Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.Keratinocytes in allergic skin diseases.The same sequence mediates activation of the human urokinase promoter by cAMP in mouse Sertoli cells and by SV40 large T antigen in COS cells.Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.Direct evidence that the mouse sex-determining gene Sry is expressed in the somatic cells of male fetal gonads and in the germ cell line in the adult testis.Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic modelThe role of oncogenic Ras in human skin tumorigenesis depends on the clonogenic potential of the founding keratinocytes.IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes.Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment.Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses.Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis.IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response.Knockout of the Arp2/3 complex in epidermis causes a psoriasis-like disease hallmarked by hyperactivation of transcription factor Nrf2.Expression of the Xist gene in urogenital ridges of midgestation male embryos.Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3.IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans.IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatmentEffector and regulatory T cells in allergic contact dermatitisThe Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis.Follicle-stimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulation of DNA synthesis in spermatogonia by soluble SLFIdentification of 3',5'-cyclic adenosine monophosphate-inducible nuclear factors binding to the human urokinase promoter in mouse Sertoli cellsHuriez syndrome: case report with a detailed analysis of skin dendritic cellsInterleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytesInterferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II moleculesCetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytesSuppressor of cytokine signaling-1 inhibits interferon-gamma-induced activation of human keratinocytesSuppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1/2 activationHeterogeneity of psoriasis and bimodal activation of local immune responses
P50
Q22254640-34C6949B-7512-447F-801C-8443CA46853AQ28218891-DA0A1BB7-ACC4-42AF-9732-FEF6846A04ECQ33648604-101A6CB8-3D70-4F12-B0FA-F9F6F53E4B55Q33945724-6A61625D-5729-464F-A75E-7C8D50A9F54CQ34023370-D54BA60A-1AE5-401A-A9EF-C59486A5A2D9Q34418103-EC304737-4E90-4828-8D81-799A8A35F633Q35255673-91F4D8E1-85F3-48AA-BCB9-55B52A5E5434Q35789250-6971CED2-CD13-4D54-9E89-9B1B5EAE9B4FQ36166751-D703C2A2-844A-4A8B-BADC-17876C132553Q36365118-192586B0-2E7F-4576-875F-C6725FD2C645Q36385326-3B730856-15BA-4814-B4EB-99E9A344EB12Q37694579-C13C1999-0A40-40C4-9062-23AED23E08BCQ37778242-47408419-EA4F-4E77-B33F-9648B3536E9FQ38360150-33C931F8-45CE-4781-859D-FBBAB6A34BF9Q38930857-27A44330-3146-448D-A2A5-AAA27D1B390BQ40833931-15FF5572-6C13-4516-8A48-F3EEB5A930D0Q41564704-743B96A3-4796-4EE5-B3D4-4EC08E49284EQ42369054-D15697C1-0154-40B4-BF1F-85D558BDA7DDQ42815185-6E0E45FD-BE61-4874-BDD1-DB2550B7C0DAQ42828000-D6C8BC26-7A3B-4AC8-B5A8-1CE6F9CD1F07Q43198306-76A4F48C-6523-4B15-A187-446A26CF5F5BQ43568227-AA0AB296-1557-4BA8-A803-929CE79F42EAQ44024651-27CCBDE6-984D-4E99-AF81-89EB76E81061Q46214370-DADA242E-4391-4B1A-A9D6-C2B49B07205CQ47428767-A282DB4C-E18E-491A-9C02-4383BADE424CQ52212911-DBA478F7-552F-40A7-8FBD-DF8BBEFA023AQ53287832-1329FDC1-4F80-45FB-8016-7E5C779A1FF0Q54379262-C51AC502-D032-4FCC-AB64-DE95F2A81BCAQ58093804-BD7B2AD8-CD0A-4815-A35E-47C62265DE03Q61703544-D49DF589-D4DE-40CF-8758-31BAA5F8DA60Q64884999-CEF2F855-77D7-49A9-A9C7-C3768D0321DDQ72066844-3A1FCC51-F1D1-47C7-91A0-B34967731E39Q72623962-0EBC7E29-0A82-4901-8EB3-34036D7BD693Q73167380-6919CD05-4E04-4979-B0B7-B08968A5F6E3Q73969172-74A4D4B1-37C9-4243-A970-58F3EA8845F2Q74150090-6E5ED3E9-3C9D-4C19-8FFF-284FB7542EA9Q74429291-A1439BF5-E031-4AD7-A7F2-854B1BD2FED2Q78673879-30FA37B8-95D8-4877-83B1-04BCC50FF38DQ81461528-F7843889-7CC4-4CAF-96B0-2D5035F48743Q87130186-642C03E9-8FC1-42DA-B72E-705C92337305
P50
description
researcher
@en
name
C Albanesi
@en
C Albanesi
@nl
type
label
C Albanesi
@en
C Albanesi
@nl
prefLabel
C Albanesi
@en
C Albanesi
@nl
P106
P31
P496
0000-0002-7537-6833